Prices checked Nov 2, 2026
GLP-1 pill cost: the Wegovy pill and Foundayo against the shot
The Wegovy pill costs $149 a month at the 1.5mg starter dose through NovoCare, $199 at 4mg, and $299 at 9mg and at 25mg, the dose you stay on. Foundayo, Lilly's pill, costs $149 a month at 0.8mg and $349 at 14.5mg and 17.2mg from Lilly. The top two doses drop to $299 when you refill within 45 days of your last delivery.
Two cash programs to check, priced for the weekly shot.
No insurance needed.
- Check price →
- SnagRx$99 a monthBilled monthly. The 12-month plan is $69 a month, billed as $828 up front.compounded semaglutideCheck price →SnagRx's homepage shows its 12-month prepaid prices first
For three years, the GLP-1 choice was binary: injectable or nothing. The December 2025 FDA approval of the Wegovy pill (oral semaglutide for weight management) changed that.
It is cheaper at maintenance than the injectable Wegovy and costs more than compounded injectable semaglutide. Whether it belongs in your plan depends on three numbers: what you are paying now, whether you inject weekly, and whether you have insurance covering one format but not the other.
- The Wegovy pill ($299/mo at maintenance) is cheaper than the Wegovy injection ($349-$399/mo) at the same NovoCare cash price point.
- Compounded injectable semaglutide is still cheaper than the pill at $59-$249/mo from the main telehealth programs, but it is not FDA-approved and carries supply risk.
- Rybelsus is not the Wegovy pill. Rybelsus is oral semaglutide with a type 2 diabetes indication. It has no weight-loss indication. Its cash price was about $998 a month when we read it on June 20, 2026.
- Tirzepatide (Zepbound) has the strongest published weight-loss result of any injectable here. SURMOUNT-1 measured about 20% average weight loss at 15mg a week, against about 15% for injectable semaglutide in STEP 1. Those are separate clinical trials in different populations.
- The Wegovy pill's $149 price covers the 1.5mg starter dose only. The 4mg step is $199/month and maintenance is $299/month.
What the oral approval actually changed
The Wegovy pill is not Novo Nordisk's first oral semaglutide. That was Rybelsus (2019), a 3mg to 14mg tablet for type 2 diabetes that doctors sometimes prescribed off-label for weight management. Its cash price without insurance was about $998 a month when we read it on June 20, 2026. The Wegovy pill is a distinct product, approved specifically for chronic weight management, with a dedicated NovoCare cash program pricing it at $149/mo for the 1.5mg starter dose and $299/month for maintenance.
That $299 maintenance price matters because the branded injectable path through NovoCare runs$349-$399/month after the intro period. For a cash-pay patient on branded semaglutide, switching from the shot to the pill saves $50-$100 a month. It is the same molecule from the same manufacturer, held to the same regulatory approval standard. The tradeoff is a daily pill taken on an empty stomach instead of a once-weekly injection.
Compounded injectable semaglutide still undercuts both, from $59/mo at the cheapest telehealth programs. But that comparison involves a different regulatory chain: 503A-compounded, with supply continuity tied to pharmacy compliance and ongoing litigation around tirzepatide.
Every format compared
Prices checked Nov 2, 2026 unless the row names an older read. Cash prices only. Insurance copays excluded.
| Format | Regulatory status | Cash price | Dosing schedule | Availability |
|---|---|---|---|---|
| Compounded semaglutide (injectable) | Not FDA-approved (503A pharmacy) | From $59/mo Collective, drug price, plus $199 yearly membership; CoreAge Rx $79 flat | Weekly self-injection | Most US telehealth programs; supply risk under litigation |
| Wegovy injection (branded) | FDA-approved (Novo Nordisk) | $349-$399/mo NovoCare cash, after intro offer; intro $199/mo for the first 2 fills at 0.25mg and 0.5mg, new patients, through Dec 31 2026 | Weekly self-injection (0.25mg-2.4mg) | Broad; insurance coverage growing after CMS ruling |
| Wegovy pill (oral, branded) | FDA-approved (Novo Nordisk, December 2025) | $149/mo starter / $299/mo maintenance NovoCare: $149 for the 1.5mg starter dose, $199 for 4mg, $299 for 9mg and for 25mg, the dose you stay on | Daily oral tablet, empty stomach | Hims, Ro, WeightWatchers Clinic, Knownwell, NovoCare direct |
| Ozempic (injectable semaglutide, T2D) | FDA-approved for T2D (Novo Nordisk) | $1,027.51/mo list price without insurance Novo Nordisk list price, checked October 29, 2026; NovoCare savings card requires T2D Rx | Weekly self-injection (0.25mg-2mg) | Requires T2D diagnosis for on-label prescribing |
| Rybelsus (oral semaglutide, T2D) | FDA-approved for T2D (Novo Nordisk, 2019) | about $998/mo cash without insurance Cash retail, read June 20, 2026; covered with T2D diagnosis | Daily oral tablet, empty stomach | Requires T2D diagnosis for on-label prescribing |
| Mounjaro / Zepbound injection (tirzepatide) | FDA-approved: Zepbound (weight loss), Mounjaro (T2D) | Zepbound: $299-$699/mo by dose (vial or KwikPen), $449/mo at 7.5mg and up with refills within 45 days LillyDirect cash, read November 2, 2026. Mounjaro needs a type 2 diabetes prescription and we publish no cash counter price for it. | Weekly self-injection (2.5mg-15mg) | Zepbound via telehealth for weight loss; Mounjaro requires T2D Rx |
| Compounded tirzepatide (injectable) | Not FDA-approved (503A pharmacy) | From $69/mo Collective, drug price, plus $199 yearly membership; Eden $129 flat at every dose; under active Lilly litigation | Weekly self-injection | Limited; FDA enforcement and Lilly litigation create supply risk |
Source: the price behind each row plus the NovoCare and LillyDirect cash programs. Row dates show the last read. More prices: GLP Chart Price Index.
The cost picture, format by format
Compounded injectable semaglutide: cheapest cash path
The lowest semaglutide drug price on our chart is $59/month (Collective, compounded injectable semaglutide, drug price, plus $199 yearly membership). CoreAge Rx runs $79/month, flat across every dose tier.
That flat rate is what makes compounded competitive across the full titration arc. Most programs price by dose tier, so the starter dose is cheap and the maintenance dose is more expensive. The gap between compounded and branded at the maintenance dose runs $121-$221/month depending on the program.
Compounded semaglutide is made by a 503A pharmacy against a prescription. The FDA has not reviewed it for safety, effectiveness or quality. The risk is regulatory and supply: a 503A pharmacy operates outside the branded supply chain, and an FDA enforcement action or court order can halt supply quickly. That happened with compounded tirzepatide pharmacies in 2025.
Branded injectable Wegovy: the established cash path
The branded injectable Wegovy costs $349-$399/month through NovoCare at a maintenance dose. The injection comes in pre-filled pens at 0.25mg, 0.5mg, 1mg, 1.7mg, and 2.4mg, titrating over 16 weeks. For patients with insurance covering Wegovy, the injection is the dominant path because coverage is keyed to the branded injection NDA. The pill may or may not be covered under the same benefit, depending on how the insurer coded it.
Several telehealth programs dispense branded Wegovy injection alongside the pill: Hims, Ro,WeightWatchers Clinic, and Noom Med. At Hims and Ro the membership adds $149 a month on top of the NovoCare medication price, so the month-to-month cash price for the shot at those two runs $498-$548/month. The pill at the same two programs is $448/month. Ro charges $74 a month if you prepay 12 months, $888 up front.
Wegovy pill: the new cash math
The pill is available directly via NovoCare without a telehealth program membership, which shaves the membership cost out of the all-in number. Several programs also dispense it: Hims($149/mo membership), Ro ($149/mo membership month to month, $74/mo prepaid for 12 months), WeightWatchers Clinic ($74/mo membership on the 12-month plan, $25 for the first month). Run the math at your specific program; membership costs matter as much as the NovoCare pill price.
See the Wegovy pill cost by dose and by where you buy it.
The pill requires a specific administration protocol: one tablet on an empty stomach with up to 4 oz of plain water, at least 30 minutes before eating, drinking anything other than water, or taking other medications. Missing that window reduces absorption. Patients who travel frequently, eat breakfast early, or take morning medications will find the daily injection-free routine trades one inconvenience for another.
Zepbound (tirzepatide): highest efficacy, injectable only
Tirzepatide remains injectable-only as of this writing. There is no approved oral tirzepatide for weight loss. Zepbound vials run $299-$699/month through LillyDirect depending on dose, or $449 at 7.5mg and up if you refill within 45 days. See the Zepbound KwikPen price by dose. compounded tirzepatide starts at $69/month, drug price, plus $199 yearly membership through Collective, but carries active FDA enforcement and Lilly litigation risk.
For patients who tolerate injectable semaglutide but plateau or underrespond, tirzepatide's dual GIP/GLP-1 agonist mechanism has shown stronger weight outcomes in the SURMOUNT-1 trial (about 20% average weight loss at 15mg/week at 72 weeks).
Efficacy: what the clinical trials actually show
OASIS 4, the Wegovy pill's trial, compared the pill with placebo, not with the shot. The figures below come from separate clinical trials in different populations under different protocols.
The STEP 1 trial of injectable semaglutide at 2.4mg a week found about 15% average body weight reduction at 68 weeks (published in the NEJM, 2021). OASIS 4 tested 25mg once a day, the pill's maintenance dose. As published in the NEJM in 2025: “The estimated mean change in body weight from baseline to week 64 was -13.6% in the oral semaglutide group and -2.2% in the placebo group.” The trial enrolled 307 people. The FDA label prints the same trial with 13.6% on the pill and 2.4% on placebo.
An earlier trial, OASIS 1, tested a higher dose: oral semaglutide 50mg once a day found 15.1% average body weight reduction at 68 weeks, against 2.4% on placebo (The Lancet, 2023). The Wegovy pill stops at 25mg.
Both formats use semaglutide. The difference is absorption. The FDA label puts absolute bioavailability, the share of a dose that reaches the blood, at 89% for the shot and about 1% to 2% for the tablet. In people without type 2 diabetes, average blood levels were similar on the 25mg pill once a day and the 2.4mg shot once a week. The pill has not been studied for weight reduction in adults with type 2 diabetes.
Which format fits which patient
Injectable semaglutide (compounded or branded) fits the patient who is tolerating injections, already getting results, and does not want to change what is working. Switching for cost makes sense if the injection path costs more than $299/month all-in and the needle is a persistent friction point.
The Wegovy pill fits the cash-pay patient who wants a branded, FDA-approved product at a lower price than the injection, and who can commit to the daily empty-stomach protocol. It does not fit the patient who takes morning medications, eats breakfast first, or frequently travels with variable schedules.
Tirzepatide (Zepbound or compounded) is the format for the patient who underresponded to semaglutide and wants a different mechanism. No oral tirzepatide is available; the injectable format is the only option. For patients who responded well to semaglutide, switching to tirzepatide for the pill-versus-shot reason is not supported by evidence.
Compounded semaglutide is the cash-pay format for the cost-limited patient who accepts the regulatory tradeoff and wants the same weekly injection schedule at $120-$220 less per month. It belongs in the decision: not FDA-approved as a finished product, supply is tied to pharmacy compliance, and the market is under active enforcement pressure.
Price watch: what changes soon
The NovoCare Wegovy injection intro is $199 a month for your first two fills. It applies to new patients at the 0.25mg and 0.5mg starter doses and runs through December 31, 2026. After that the standard cash price is $349 a month, or $399 for the 7.2mg high dose.
We track these prices every week. The GLP Chart Price Index shows the current all-in monthly cost across every US GLP-1 telehealth program, including programs that dispense the Wegovy pill.
Where to get the Wegovy pill
As of November 2, the following US telehealth programs dispense the oral Wegovy pill for weight management:
- Hims ($149/mo membership + NovoCare pill price; $448/mo all-in at maintenance, membership $39 first month)
- Ro Body ($149/mo membership month to month + NovoCare pill price;$448/mo all-in at maintenance, $373 if you prepay 12 months of membership)
- WeightWatchers Clinic ($74/mo membership on the 12-month plan + NovoCare pill price; $373/mo all-in at maintenance)
- Noom Med (via branded telehealth tier, $99/mo + medication separate)
- Knownwell (care via insurance-billed primary-care visit; NovoCare pill pricing applies; visits may be covered separately by insurance)
- NovoCare Direct (no telehealth membership; $149/mo starter, $299/mo maintenance, prescription required)
The list is expanding as programs update their formularies. Check the GLP Chart homepage for current availability flags.
Frequently asked questions
What is the cheapest GLP-1 pill without insurance?
The lowest pill price on the chart is $99 a month for the Strut Health lozenge, on auto-refill, with a written medical reason you cannot use a needle. It is compounded semaglutide, a pharmacy-made version that is not FDA-approved and is not Wegovy or Ozempic. You hold it in your mouth. The two FDA-approved weight-loss pills, Wegovy and Foundayo, each cost $149 a month at the starter dose (1.5mg for Wegovy, 0.8mg for Foundayo).
Is there a GLP-1 pill with no membership fee?
Yes. Strut Health charges no membership fee for its lozenge, and the consult and shipping are in the monthly price. NovoCare sells the Wegovy pill straight to you with no membership once you have a prescription.
Is the pill cheaper than the shot?
Yes. Through NovoCare the Wegovy pill costs $50 a month less than the Wegovy shot at the dose you stay on, and $100 less than the 7.2mg shot. They match only in month two, when the 4mg pill costs $199 and so does a new patient's second fill of the shot on the intro offer, which runs through December 31, 2026.
Is the Wegovy pill the same as Rybelsus?
No. Both are semaglutide tablets made by Novo Nordisk. Rybelsus is approved for type 2 diabetes, and the Wegovy pill is approved for chronic weight management.
Can I get a GLP-1 pill online?
Yes. A US-licensed physician reviews Strut Health's online health form and prescribes the lozenge. Ro, Sesame Care and Hims prescribe the Wegovy pill online, and NovoCare sells it direct once you have a prescription.
See the live price of every GLP-1 program →
Read our compounded vs. branded cost study →
Wegovy pill cost by dose and by where you buy it →
Foundayo cost without insurance by dose →
Zepbound KwikPen cost by dose →
Compare GLP-1 drugs head to head (semaglutide vs tirzepatide, Wegovy vs Zepbound) →
Wegovy dosage schedule: every step on the FDA label →
Wegovy pill side effects, from the FDA label →
Orforglipron (Foundayo), Lilly's GLP-1 pill: the 2026 buyer's guide →